OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, January 2nd

OTCPicks Publisher Newsletter

OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, January 2nd BIOF, ATTD, BCRX, SYNM, AMBS, PAYD Our Stocks to Watch today include BioFuel Energy Corp. (NASDAQ : BIOF), Attitude Drinks Inc. (OTCBB: ATTD), BioCryst Pharmaceuticals Inc. (Nasdaq:

BCRX), Syntroleum Corp. (Nasdaq: SYNM), Amarantus Biosciences Inc. (OTCBB:

AMBS) and Paid Inc. (OTCBB: PAYD).

Visit http://otcpicknews.com/emailmarketer/link.phpM940&N54&L1&F=T to register for our Daily Market Movers Digest Newsletter and Email Stock Watch Alerts.

BIOFUEL ENERGY CORPORATION (NASDAQ: BIOF) “Up 28.26% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N54&L87&F=T BioFuel Energy Corp. engages in the production of ethanol in the United States. It has two ethanol plants that produce 115 million gallons per year, which are located in Wood River, Nebraska and Fairmont, Minnesota.

The company was founded in 2006 and is headquartered in Denver, Colorado.

BIOF News:

December 24 – Recent AAA Survey Shows Just 5% Cars and Trucks in the U.S.

Approved to Use E15 Fuel The Paragon Report Provides Stock Research on BioFuel Energy and Pacific Ethanol Ethanol stocks have struggled as of late as a recent survey of automakers conducted by the AAA showed that just 5 percent of the 240 million cars and trucks in the U.S. are approved to use E15 ethanol fuels. The Paragon Report examines investing opportunities in the Ethanol Industry and provides equity research on BioFuel Energy Corp. (NASDAQ : BIOF) and Pacific Ethanol Inc. (NASDAQ : PEIX).

Access to the full company reports can be found at:

www.ParagonReport.com/BIOF www.ParagonReport.com/PEIX Since the Environmental Protection Agency approved E15 ethanol fuel, which is a 15% Ethanol and 85% Gasoline blend, for sale, only 10 filling stations in the U.S. are currently offering the fuel. Major auto manufacturers have said the fuel could cause damage to a majority of the older cars on the road, while several manufacturers have stated they will not cover any engine damage caused by the new blend.

“It is clear that millions of Americans are unfamiliar with E15, which means there is a strong possibility that many motorists may improperly fill up using this gasoline and damage their vehicle,” said AAA President & CEO Robert Darbelnet. “Bringing E15 to the market without adequate safeguards does not responsibly meet the needs of consumers.” Paragon Report releases regular market updates on the Ethanol Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.ParagonReport.com and get exclusive access to our numerous stock reports and industry newsletters.

BioFuel Energy owns and operates two of the largest dry mill ethanol facilities in the United States. The company produces 230 million gallons per year of fuel grade ethanol and 720,000 tons of distillers grains at these facilities and deliver these products to fuel blenders and agricultural users both locally and nationwide.

Serving integrated oil companies and gasoline marketers who blend ethanol into gasoline, Pacific Ethanol provides transportation, storage and delivery of ethanol through third-party service providers in the Western United States. The company recently reported that it has implemented corn oil separation technology at their Stockton Plant.

ATTITUDE DRINKS INCORPORATED (OTCBB: ATTD) “Up 50.00% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N54&L40&F=T Attitude Drinks Inc. is an innovative, beverage brand development company with a focus on functional milk, ready-to-drink beverages. Phase III Recovery Drink is the company`s first, functional milk drink exploiting recent scientific evidence of the benefits of milk and protein as an exercise recovery aid. The February 2010 launch of Phase III marks the first time a sports drink has been formulated from real milk.

ATTD News:

December 6 – Attitude Drinks Adds Daily`s Convenience Store Chain in Tennessee and Kentucky Det Distribution and Hand Family Distributors Delivering Phase III Recovery Attitude Drinks (OTCBB: ATTD), an innovative beverage brand development company and creator of the Phase III Recovery brand, today announced a sales authorization for Phase III Recovery with Daily`s Convenience Stores. Daily`s has always been locally owned and operated and strives to provide the finest service available anywhere through its 80 locations in middle Tennessee and Kentucky.

Det Distribution Company is handling Phase III through their two distribution centers in Kentucky, and The Hand Family Distributors is carrying Phase III through their five service outlets, two in Kentucky and three in Tennessee.

Jack Shea, EVP Sales said, “The addition of Daily`s Convenience Stores to the growing roster of Phase III Recovery retailers is very good news.

Consumers in Tennessee and Kentucky will now be able to purchase Phase III, the only recovery drink on the market that has the perfect ratio of carb grams to protein grams to ensure efficient muscle recovery after exercise.” Bob Hearn, Regional Sales Manager said, “We are proud to partner with these two fine distributors in this region. Relationships with distributors and retailers like these perfectly reflect the integrity and professionalism needed to establish Phase III in this market.” BIOCRYST PHARMACEUTICALS INCORPORATED (NASDAQ: BCRX) “Up 11.45% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N54&L8&F=T BioCryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that block key enzymes involved in infectious and inflammatory diseases. BioCryst currently has two late-stage programs:

peramivir, a viral neuraminidase inhibitor for the treatment of influenza, and ulodesine (BCX4208), a purine nucleoside phosphorylase (PNP) inhibitor for the treatment of gout. In addition, BioCryst is advancing two preclinical programs: BCX5191, a nucleoside analog inhibitor of HCV RNA polymerase (NS5B) for hepatitis C, and BCX4161, an oral inhibitor of plasma kallikrein for hereditary angioedema. Utilizing state-of-the-art structure-guided drug design and crystallography, BioCryst continues to discover innovative compounds with the goal of addressing unmet medical needs of patients and physicians.

BCRX News:

December 7 – BioCryst Pharmaceuticals Announces Focused Corporate Strategy and Restructuring 2013 cash utilization projected to drop 38-45% versus 2012 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced that in response to recent events and an assessment of its assets, the Company is restructuring and implementing a focused strategy to advance its hereditary angioedema (HAE) and antiviral programs. The restructuring is intended to significantly reduce BioCrysts cost structure and scale the organization appropriately for its current portfolio. The Company plans to direct its cash and other resources primarily to enable the achievement of important near-term milestones for the BCX4161 HAE, BCX4430 broad spectrum antiviral and BCX5191 hepatitis C (HCV) programs.

The strategic focus and restructuring announced today is based on an evaluation of our programs and operations, following the setbacks in our peramivir and BCX5191 programs, as well as the delay in our BCX4161 program, said Jon P. Stonehouse, President & Chief Executive Officer of BioCryst. The restructuring is a necessary but difficult measure that impacts many talented and dedicated BioCryst employees who will be leaving the company. We are grateful for their meaningful contributions and commitment over the years.

Mr. Stonehouse continued, We have determined the best path forward and remain committed to advancing our HAE and antiviral programs to rebuild shareholder value. To succeed, we must significantly decrease our operating costs and carefully manage cash, while efficiently advancing our three priority programs. Therefore, we are implementing a substantial corporate restructuring to decrease our annual cash utilization and thereby extend our cash runway. The restructuring provides additional cash runway to reach value inflection points for these programs.

BioCrysts corporate restructuring includes a workforce reduction of 50 percent of the Companys headcount, or 38 positions. Excluding restructuring and deal charges, cash savings of $15 to $18 million are expected in 2013, as compared to an approximate $40 million cash use expected in 2012. The Company expects to record a restructuring charge of $2 to $4 million in the fourth quarter of 2012. For 2013, preliminary cash utilization guidance is in the range of $22 to $25 million, excluding restructuring and deal related costs. Detailed financial guidance for 2013 will be provided with the fiscal 2012 results announcement in February 2013.

Program Updates & Milestones * BioCryst is conducting a study to characterize the efficacy of low doses of BCX5191 in chronically HCV infected chimpanzees, with the goal of demonstrating meaningful antiviral activity at low doses. Results from the study are expected in early 2013.

* By the end of January 2013, BioCryst plans to complete analysis of the peramivir Phase 3 trial results and to review the conclusions with HHS/BARDA. After reviewing the totality of peramivir clinical safety and efficacy data, a decision will be made regarding peramivirs future.

* The BCX4161 Phase 1 program is expected to start around the end of the first quarter 2013. The goal of this program is to demonstrate safety, adequate drug exposure via oral administration and pharmacodynamic effect on kallikrein inhibition.

* A manuscript describing the activity of BCX4430 against certain filoviruses has recently been submitted to a journal for consideration. In addition, BioCryst has submitted a proposal to seek additional government funding for the development of BCX4430 under the animal rule.

* The Companys strategy for the ulodesine gout program remains unchanged. BioCryst intends to secure a partner to take over the ulodesine Phase 3 development and to commercialize the product.

SYNTROLEUM CORPORATION (NASDAQ: SYNM) “Up 16.46% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N54&L57&F=T Syntroleum Corporation owns the Syntroleum Process for Fischer-Tropsch (FT) conversion of synthesis gas into liquid hydrocarbons, the Synfining Process for upgrading FT liquid hydrocarbons into refined petroleum products, and the Bio-Synfining technology for converting renewable feedstocks into drop-in fuels. Syntroleum has a 50% interest in Dynamic Fuels, LLC, which operates a 75 million gallon per year renewable fuels facility located in Geismar, Louisiana utilizing its Bio-Synfining technology.

SYNM News:

December 18 – Syntroleum Vigorously Defends Bio-Synfining Technology Against Neste Allegations-NasdaqCM On December 20, 2012, Syntroleum Corporation (Nasdaq: SYNM) was sued for alleged patent infringement in the District of Delaware by Neste Oil Oyj regarding U.S. Patent No. 8,212,094. The `094 patent covers similar subject matter and shares a common inventor with prior Neste patents (U.S. Patent Nos. 7,279,018 and 8,187,344), as they are directed to processes for making, or compositions of, diesel fuel or diesel range hydrocarbons.

Syntroleum has not infringed any of Neste`s alleged patent rights and Syntroleum will continue to vigorously defend against Neste`s allegations.

The `094 patent, like the `018 and `344 patents, adds nothing new to the field of diesel fuels or methods for making same.

All claims of Neste`s prior `018 patent were invalidated following a March 22, 2012 decision by the USPTO Board of Patent Appeals and Interferences finding that “the evidence of record as a whole supports the Examiner`s conclusion that the fuel composition as claimed would have been obvious to one of ordinary skill in the art…” Neste declined to appeal this ruling and on July 31, 2012, the USPTO issued a Reexamination Certificate canceling all claims of the `018 patent. Likewise, the related `344 patent is the subject of an inter partes reexamination wherein the USPTO issued a September 14, 2012 Office Action rejecting all claims of that patent as obvious in view of the prior art. This reexamination is pending and is assigned Reexam Control Number 95002084.

Syntroleum is currently defending Neste`s suit filed May 29, 2012 on the `344 patent in the District of Delaware. Syntroleum`s Answer and Counterclaims to Neste`s First Amended Complaint regarding the `344 patent was filed on September 24, 2012, and Syntroleum`s Motion to Stay the district court action in view of the USPTO reexamination proceedings is pending. Syntroleum will pursue its non-infringement, invalidity and other defenses with respect to both asserted Neste patents and is confident that its position will be vindicated.

AMARANTUS BIOSCIENCES INCORPORATED (OTCBB: AMBS) “Up 31.06% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N54&L59&F=T Amarantus BioSciences, Inc. is a California-based development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat Parkinsons disease and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF“).

AMBS News:

January 2 – Fiscal Cliff Closed: Futures Indicating Higher on Wall Street After Closing the Deal Wall Street can embrace closure when its headlines have been hogging the news, and it looks like that`s the case today. We have seen President Obama follow through on his vow to raise taxes on the wealthy. Couples making more than $450,000 a year in the United States are now considered rich.

Those lucky people will see their tax rate rise to 39.6%.

World Moto (OTCBB: FARE) had a strong couple of days` trading going into the New Year after being higher by over 10% on an increased $4 million in trading. This was much higher volume on FARE than we saw earlier last week.

The last few days` trading have bought total volume of around $15 million and the stock has been higher three days running. The surprising thing here is that it has come on some of the lightest volume days of the year.

AMR Corp (OTC: AAMRQ) was back in the news yesterday after trading over $2 million in volume on the day. AAMRQ closed flat after trading higher earlier in the session. The stock has been sitting around the 0.80 cent mark for a while now after testing the $1.00 mark earlier in December.

Amarantus Biosciences (OTCBB: AMBS) is another stock that`s had an impressive run back over the last few trading sessions. The volume has been increasing in shares of AMBS and the stock has doubled in price over the last week. The volume in yesterday`s trading was $1.7 million with the stock up 22%.

USA Graphite (OTCBB: USGT) has been receiving a lot of attention in the OTC markets over the last week and traded over $1.7 million in trading on Tuesday whilst being higher by 3%.

The Gap (NYSE: GPS) has been trading heavily recently after becoming the company of the year featured on Yahoo Finance. The retail stocks have been in the headlines recently with a worse than expected holiday season. Some analysts are reporting that certain companies like The Gap could have performed better than most, and could be taken a look at for longer term investments. Shares of Gap were higher by 2% on almost 5 million shares on the close yesterday.

PAID INCORPORATED (OTCBB: PAYD) “Up 57.14% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N54&L58&F=T Paid, Inc. focuses on providing brand-related services to businesses, celebrity clients in the entertainment industry, and charitable organizations. The companys brand management, brand marketing, social media marketing, product design and merchandising, and website design, as well as development and hosting services help its clients in growing their customer base in size, loyalty, and revenue generation. It offers entertainers and business entities Web-presence and related services supporting and managing clients official Websites and fan-community services, including e-commerce, VIP ticketing, live event fan experiences, user-generated content, client content publishing and distribution, fan forums, social network management, and social media marketing, as well as customer data capture, management, and analysis. Its brand support services also comprise design and production of print, audio, and video promotion marketing materials for client branded products and events. In addition, Paid, Inc. sells merchandise for celebrities and businesses through official Website stores and other Web-based outlets, and on-tour and retail outlets. Further, the company, through AuctionInc, offers a suite of online shipping management tools, which assist businesses with e-commerce storefronts, shipping solutions, inventory management, and auction processing. Paid, Inc. was founded in 1986 and is headquartered in Westborough, Massachusetts.

PAYD News:

No recent news for Paid, Inc. (OTCBB: PAYD).

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company`s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company`s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company`s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://otcpicknews.com/emailmarketer/link.phpM940&N54&L=7&F=T and FINRA at http://otcpicknews.com/emailmarketer/link.phpM940&N54&L=8&F=T.

Disclosure: OTCPicks.com is not currently being compensated by any of the companies covered in this release.

Related posts:

1. OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, January 2nd
2. OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, September 25th
3. OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, September 26th
4. OTCPicks.com Daily Market Movers Digest Midday Report for Monday, October 8th
5. OTCPicks.com Stocks to Watch for Tuesday, October 9th